mass array compact system (agena bioscience)
97
Structured Review
agena bioscience
mass array compact system
Mass Array Compact System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 19746 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+compact/MassARRAY+Compact/pmc12444925-103-10-14
Average 97 stars, based on 19746 article reviews
Mass Array Compact System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 19746 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+compact/MassARRAY+Compact/pmc12444925-103-10-14
Average 97 stars, based on 19746 article reviews
mass array compact system - by Bioz Stars,
2026-11
97/100 stars
Images
Related Articles
Methylation:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Methylated DNA Immunoprecipitation:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Software:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Polymerase Chain Reaction:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Multiplex Assay:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Amplification:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Multiplex PCR:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Cell Culture:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. Bisulfite Conversion Based PCR Assay:Article Title: Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC. Article Snippet: Extraction of genomic DNA from FFPE tissue was performed as previously described [19,20] or by use of the QIAamp DNA FFPE Tissue Kit (Qiagen, Germany) according to manufacturer’s protocol. |